evaluate novo nordisk on glp-1 agonists Oral GLP-1-Based Therapeutics in the Obesity–Metabolic Syndrome–Diabetes Continuum: Translational Advances, Clinical Barriers, and Emerging Strategies How GLP-1 Receptor Agonists Evolved
Description
Effects of weight loss interventions for adults who are obese on mortality, cardiovascular disease, and cancer: systematic review and meta-analysis
Front Pharmacol (2020) 11:356
[DOI] [PubMed] [Google Scholar] 83.Li L, Shen J, Bala MM, Busse JW, Ebrahim S, Vandvik PO, Rios LP, Malaga G, Wong E, Sohani Z
Preclinical studies have demonstrated that DPP-4 inhibitors significantly prevent the onset of liver cancer in MC4R-KO mice [111]
-agonists-market-key-insight.png)
Han B, et al
